Home › Funds › Sanofi › ODTX

Sanofi position in ODTX

Odyssey Therapeutics Inc. · Health Care

Sanofi reported holding 1,990,200 shares of ODTX (Odyssey Therapeutics Inc.) in its Q3 2026 13F filing — a position valued at US$44.2M, representing 7.02% of its reported portfolio and ranking #5 among its reported holdings. Sanofi has disclosed ODTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)1.99M sh
Reported value held$44.22M
Portfolio Weight7.02%
First reportedQ2 2026
Last changeHold
Updated2026-11-05

Last updated: 2026-11-05 · Source: SEC EDGAR Form 13F-HR

How Sanofi's ODTX position evolved

Sanofi first disclosed a stake in ODTX in Q2 2026 at 1,991,918 shares (US$37.3M). The position peaked in Q3 2026 at 1,990,200 shares, worth US$44.2M. Across 2 filings, Sanofi held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,990,200 shares valued at US$44.2M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.99M $37.27M New
Q3 2026 1.99M $44.22M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ODTX and 13F data

ODTX (Odyssey Therapeutics Inc.) is a Health Care company. 64 other funds we track also report a position in ODTX — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$71.0M), TPG GP A, LLC (US$69.0M), Lightspeed Management Company, L.L.C. (US$67.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ODTX

All ODTX fund holders →

FAQ

How long has Sanofi held ODTX?

Sanofi has disclosed ODTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Sanofi's current position in ODTX?

As of Q3 2026, Sanofi holds 1.99M shares of ODTX (Odyssey Therapeutics Inc.), valued at $44.22M, representing 7.02% of its reported portfolio and ranking #5.

Has Sanofi been buying or selling ODTX?

In the latest 13F filing (Q3 2026), Sanofi held unchanged its position in ODTX. The position peaked in Q3 2026 at 1.99M shares.

Which other funds hold ODTX?

Other major institutional holders of ODTX include SR ONE CAPITAL MANAGEMENT, LP, TPG GP A, LLC, Lightspeed Management Company, L.L.C., among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.